B.P. England

1.3k total citations
10 papers, 912 citations indexed

About

B.P. England is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, B.P. England has authored 10 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in B.P. England's work include Polyamine Metabolism and Applications (2 papers), Epigenetics and DNA Methylation (2 papers) and Receptor Mechanisms and Signaling (2 papers). B.P. England is often cited by papers focused on Polyamine Metabolism and Applications (2 papers), Epigenetics and DNA Methylation (2 papers) and Receptor Mechanisms and Signaling (2 papers). B.P. England collaborates with scholars based in United States, Ecuador and United Kingdom. B.P. England's co-authors include Robert Tjian, Ulrike Heberlein, G.L. Card, Michael V. Milburn, Prabha N. Ibrahim, S. Gillette, Dean R. Artis, Sung‐Hou Kim, Joseph Schlessinger and Daniel W. Fong and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

B.P. England

10 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.P. England United States 8 735 227 217 106 93 10 912
Jill S. Gregory United States 12 968 1.3× 180 0.8× 100 0.5× 91 0.9× 42 0.5× 15 1.3k
Tsutomu Agatsuma Japan 16 767 1.0× 217 1.0× 272 1.3× 82 0.8× 30 0.3× 22 1.1k
Ireos Filipuzzi Switzerland 13 687 0.9× 63 0.3× 72 0.3× 67 0.6× 141 1.5× 21 897
Ryszard Szyszka Poland 19 700 1.0× 110 0.5× 53 0.2× 45 0.4× 52 0.6× 47 891
Patrik Johansson Sweden 15 409 0.6× 130 0.6× 141 0.6× 113 1.1× 67 0.7× 20 641
Gina M. Clayton United States 11 438 0.6× 99 0.4× 73 0.3× 25 0.2× 139 1.5× 12 790
Yusuke Tominari Japan 9 472 0.6× 75 0.3× 112 0.5× 67 0.6× 35 0.4× 10 708
Serdar Kurtkaya United States 8 434 0.6× 158 0.7× 83 0.4× 23 0.2× 34 0.4× 8 756
Émilie Durieu France 18 407 0.6× 313 1.4× 88 0.4× 42 0.4× 70 0.8× 26 874
Emilio Dı́ez Spain 14 454 0.6× 48 0.2× 109 0.5× 30 0.3× 63 0.7× 21 713

Countries citing papers authored by B.P. England

Since Specialization
Citations

This map shows the geographic impact of B.P. England's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.P. England with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.P. England more than expected).

Fields of papers citing papers by B.P. England

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.P. England. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.P. England. The network helps show where B.P. England may publish in the future.

Co-authorship network of co-authors of B.P. England

This figure shows the co-authorship network connecting the top 25 collaborators of B.P. England. A scholar is included among the top collaborators of B.P. England based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.P. England. B.P. England is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Card, G.L., B.P. England, Chao Zhang, et al.. (2005). A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design. Nature Biotechnology. 23(2). 201–207. 145 indexed citations
2.
Card, G.L., B.P. England, Yoshihisa Suzuki, et al.. (2004). Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases. Structure. 12(12). 2233–2247. 338 indexed citations
3.
Uings, Iain, Balasubramanian Palaniappan, Alan Beresford, et al.. (2001). MODIFIED PEPTIDE ANTAGONISTS OF INTERLEUKIN 5 EXHIBIT EXTENDED IN VIVO PERSISTENCE BUT RESTRICTED SPECIES SPECIFICITY. Cytokine. 15(1). 10–19. 4 indexed citations
4.
England, B.P., Balasubramanian Palaniappan, Iain Uings, et al.. (2000). A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor α chains. Proceedings of the National Academy of Sciences. 97(12). 6862–6867. 41 indexed citations
5.
GORDEEV, M. F., et al.. (1998). Combinatorial synthesis and screening of a chemical library of 1,4-dihydropyridine calcium channel blockers. Bioorganic & Medicinal Chemistry. 6(7). 883–889. 39 indexed citations
6.
Sloan, Derek D., Ronald W. Barrett, Emily Tate, & B.P. England. (1997). Expression of an Epitope Tagged Human C5a Receptor and Antibody-Mediated Immobilization of Detergent-Solubilized Receptor for Drug Discovery Screening. Protein Expression and Purification. 11(1). 119–124. 1 indexed citations
7.
England, B.P., Arie Admon, & Robert Tjian. (1992). Cloning of Drosophila transcription factor Adf-1 reveals homology to Myb oncoproteins.. Proceedings of the National Academy of Sciences. 89(2). 683–687. 52 indexed citations
8.
9.
England, B.P., Ulrike Heberlein, & Robert Tjian. (1990). Purified Drosophila transcription factor, Adh distal factor-1 (Adf-1), binds to sites in several Drosophila promoters and activates transcription.. Journal of Biological Chemistry. 265(9). 5086–5094. 56 indexed citations
10.
Heberlein, Ulrike, B.P. England, & Robert Tjian. (1985). Characterization of drosophila transcription factors that activate the tandem promoters of the alcohol dehydrogenase gene. Cell. 41(3). 965–977. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026